3569 results for «250»
3569 results
Miscellaneous - Paravalvular leak closure, PFO closure and LAA occlusion
21 Nov 2021 – From PCR London Valves 2021
Want to know more about the impact of baseline PFO anatomy on residual right to left shunt after transcatheter closure, transcatheter closure of paravalvular leak, or even percutaneous mitral paravalvular leak closure using CT planning? This PCR London Valves 2021 session is for you!
Seeing is believing: predictable and durable treatment of mitral regurgitation across etiologies with the PASCAL platform
23 Nov 2021 – From PCR London Valves
Explore the clinical impact of the Edwards portfolio of transcatheter devices for mitral regurgitation treatment in this PCR London Valves 2021 session that you shouldn't miss if you want to attend case-based discussions that will analyze key PASCAL features to treat mitral regurgitation and to participate...
PCR London Valves 2021 Hotlines / Late-Breaking Trials: bRIGHT, EXPAND, CHOICE-MI
21 Nov 2021 – From PCR London Valves
Real-world outcomes for tricuspid edge-to-edge repair, predictors of heart failure hospitalisation and its impact on clinical outcomes, one-year outcomes after TMVI... View part of the Late-Breaking Trials presented during PCR London Valves 2021.
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options
21 Nov 2021 – From PCR London Valves 2021
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned. Bernard Prendergast, Philipp Lurz, Fabien Praz and Maurizio Taramasso discuss the challenges and needs regarding mitral and tricuspid valve disease treatment. They also consider what is needed to...
From TAVI to mitral and tricuspid - Applying evidence to expand patients' treatment options - Part 1 - Best long-term outcomes start with the first procedure
21 Nov 2021 – From PCR London Valves
In this session from PCR London Valve 2021 dedicated to TAVI, mitral, and tricuspid, let's examine the issues related to the lifetime patient journey faced by many patients, starting with an analysis of severe aortic stenosis: how to identify the most important factors when considering the...
From TAVI to mitral and tricupid - Applying evidence to expand patients' treatment options - Part 2 - Securing long-term patient options
22 Nov 2021 – From PCR London Valves
Nowadays, there is an increasing range of treatment options as far as tricuspid and mitral regurgitations are concerned, as you can notice in this session broadcast at PCR London Valves 2021 Congress, focusing on this topic area. Watch it now if you wish to understand how key...
Predictability at release means better MR outcomes; PASCAL platform significance in a matched analysis
21 Nov 2021 – From PCR London Valves 2021
Join Peter Lüdike and Philipp Lurz to learn more about about the latest study regarding the predictability of mitral regurgitation reduction using the PASCAL device.
Innovation and imaging guidance for tricuspid valve replacement
21 Nov 2021 – From PCR London Valves
Watch this TNT session broadcast at PCR London Valves 2021 Congress to learn more about the crucial importance of understanding imaging and having high-quality imaging to guide transcatheter tricuspid valve intervention.
EAPCI: patient initiatives around the world
22 Nov 2021 – From PCR London Valves 2021
In this session, you can find out more about the EAPCI Valve for Life initiative and what progress has been made in selected countries, as well as other collaborative initiatives across the world.
HighLife TSMVR study status and new developments
22 Nov 2021 – From PCR London Valves 2021
Watch this session from the PCR London Valves 2021 Congress to find out more about HighLife systems and how it works, to witness a live recorded case presentation, to get clinical data, and to get an idea of the upcoming future alterations of the device to...
New 2021 ESC heart failure and valvular heart diseases guidelines : impact on secondary mitral regurgitation management
21 Nov 2021 – From PCR London Valves 2021
Join Ralph Stephan Von Bardeleben and Marco Metra if you want to learn about the new ESC 2021 guidelines in heart failure management and the key interconnections between the heart failure and the valvular heart diseases guidelines, as well as to understand how this will improve...
TAVI valve and implantation technique: the secrets for optimising outcomes
21 Nov 2021 – From PCR London Valves 2021
Join Neil Moat, Helge Möllmann, Lars Søndergaard and Ganesh Manoharan to hear the experience of an account achieve single digit permanent pacemaker implantation, to learn how to preserve coronary access for future patients' treatment, and to see how new product features can reduce paravalvular leak.
Closing TAVI with next generation suture mediated closure device
21 Nov 2021 – From PCR London Valves 2021
Join Francesco Maisano to learn more about about the Perclose ProStyle, a next generation closure device for TAVI procedures, and discover some interesting tips & tricks.
The science behind a valve designed for life
21 Nov 2021 – From PCR London Valves 2021
Join Christopher Meduri if you want to understand the features of a transcatheter heart valve that is designed to last the life of the patient, why a 3D single-piece aortic valve design can provide near normal pre-disease hemodynamics and how tissue science impacts leaflet preservation and...
A heart-team discussion for tricuspid valve intervention
21 Nov 2021 – From PCR London Valves 2021
Join Vinayak Bapat, Joao Cavalcante and Paul Sorajja to learn about how the heart-team approaches tricuspid valve intervention, how to pre-procedurally plan transcatheter tricuspid valve repair/replacement and how to intra-operatively guide TTVR using imaging.
Patient-specific implantation technique to obtain neo-commissural alignment with self-expanding transcatheter aortic valves (COMALIGN)
21 Nov 2021 – From PCR London Valves 2021
Join Lars Søndergaard and Ole De Backer if you want to learn about why patient-specific implantation techniques are important to obtain commissural alignment, which imaging techniques are needed to achieve commissural alignment, as well as how valve and delivery system designs impact outcomes and success rates.
Early neo2 registry - Full core-lab adjudicated results with the new ACURATE neo2 valve
21 Nov 2021 – From PCR London Valves 2021
Join Won-Keun Kim and Andreas Rück if you want to learn about the key features of the new ACURATE neo2 system, the latest clinical outcomes in an all-comers European patient population, as well as the independent core-lab adjudicated hemodynamic performance of this new TAVI generation.
Periprocedural outcomes of MANTA vascular closure device used in large-bore arterial access following VARC-3 definitions. More scientific evidence behind plug-based vascular closure device
21 Nov 2021 – From PCR London Valves 2021
Join Simon Redwood, Radoslaw Parma and Nicolas Van Mieghem if you want to learn about the results of the latest 120 patient MANTA registry, the best practices comparing to similar registries of the past, as well as tips and tricks on how to use MANTA vascular...
Intravascular lithotripsy: expanding the boundaries of transfemoral TAVI
21 Nov 2021 – From PCR London Valves 2021
Join Sam Dawkins, Ole De Backer and Carlo Di Mario to learn about the latest news regarding intravascular lithotripsy and how it may impact the future of transfemoral TAVI.
SURTAVI five-year outcomes - What do you need to know considering the new ESC guidelines?
21 Nov 2021 – From PCR London Valves 2021
Join Nicolas Van Mieghem, Nicole Karam and Thomas Modine to learn more about about SURTAVI five-year study outcomes and to discover which factors are impacting valve performance overtime.
